IPP-1 Inhibitors
IPP-1, also known as protein phosphatase 1 inhibitor-1, plays a critical role in cellular processes by regulating the activity of protein phosphatase 1 (PP1). PP1 is a major serine/threonine phosphatase involved in the dephosphorylation of a wide range of substrates, including proteins involved in cell cycle regulation, metabolism, and signal transduction. IPP-1 acts as a potent endogenous inhibitor of PP1, tightly regulating its activity and thereby influencing various cellular pathways. Through its interaction with PP1, IPP-1 modulates processes such as glycogen metabolism, cardiac function, and neuronal signaling, highlighting its importance in maintaining cellular homeostasis.
The inhibition of IPP-1 involves intricate mechanisms aimed at regulating its interaction with PP1 and modulating PP1 activity. Several factors contribute to the inhibition of IPP-1, including post-translational modifications, protein-protein interactions, and intracellular signaling pathways. Phosphorylation of IPP-1 at specific sites has been shown to enhance its inhibitory activity towards PP1, effectively blocking the dephosphorylation of substrates and influencing downstream cellular responses. Additionally, binding partners of IPP-1, such as inhibitor-2, can further potentiate its inhibitory effects on PP1 activity. Furthermore, signaling pathways activated by cellular stimuli can regulate IPP-1 activity, providing dynamic control over PP1-mediated dephosphorylation events. Understanding the mechanisms underlying IPP-1 inhibition offers insights into the regulation of PP1 activity and its implications for cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits IPP-1 by blocking protein phosphatase 2A (PP2A), a crucial regulator of IPP-1. By preventing PP2A activity, okadaic acid disrupts the balance in phosphorylation levels, resulting in sustained activation of IPP-1 and interference with cellular processes dependent on IPP-1-mediated dephosphorylation. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin acts as an IPP-1 inhibitor by forming a complex with PP2A, similar to okadaic acid. This complex formation hinders PP2A's normal functioning, leading to the dysregulation of IPP-1 activity and subsequent modulation of cellular processes influenced by IPP-1-mediated dephosphorylation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits IPP-1 indirectly by preventing its dephosphorylation. As a protein phosphatase inhibitor, calyculin A sustains IPP-1 phosphorylation levels, affecting its enzymatic activity and disrupting cellular processes that rely on IPP-1-mediated dephosphorylation events. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
Fostriecin inhibits IPP-1 by disrupting PP2A function. Through its interaction with PP2A, fostriecin interferes with the regulatory processes governing IPP-1 activity, causing alterations in cellular processes that depend on IPP-1-mediated dephosphorylation events. | ||||||
LB-100 | 1632032-53-1 | sc-507368 | 10 mg | $330.00 | ||
LB-100 inhibits IPP-1 by selectively targeting PP2A. Through the inhibition of PP2A, LB-100 disrupts the balance of phosphorylation events regulated by IPP-1, influencing cellular processes that rely on IPP-1-mediated dephosphorylation. | ||||||
CDC25 Phosphatase Inhibitor II, NSC 663284 | 383907-43-5 | sc-202987A sc-202987 sc-202987B sc-202987C | 1 mg 5 mg 10 mg 25 mg | $51.00 $241.00 $357.00 $663.00 | 4 | |
NSC663284 inhibits IPP-1 by interfering with PP1 activity. Through its impact on PP1, NSC663284 disrupts the intricate balance of phosphorylation events regulated by IPP-1, influencing cellular processes that depend on IPP-1-mediated dephosphorylation. | ||||||